Recovery Event Calendar
Understanding Your Options and How Genetics May Impact your Chance of Opioid Addiction
According to new research, one in 10 patients admit they’ve become addicted to or dependent on opioids after being exposed to these powerful medications following an operation. This webinar will provide critical information to help patients prepare for discussing pain medication and addiction with their doctors. Presenters will share resources, including survey tools and genetic testing assets to identify a person’s potential predisposal to opioid addiction.
Peggy Compton, PhD, FAAN, RN, is a tenured associate professor at the University of Pennsylvania School of Nursing. She has published extensively in the scientific literature on substance use disorder in chronic pain patients on opioid therapy, and the pain responses of opioid addicts with and without chronic pain. Having worked in several public treatment settings, she is especially expert in the use of methadone, buprenorphine and naltrexone in the treatment of opioid use disorder. Compton has devoted her own NIH-funded research program to exploring pain and opioid addiction from both neurophysiological and clinical perspectives, with a specific interest in how the presence of one affects the expression of the other.
An accomplished researcher, author, and speaker, Compton’s excellence in the field can be seen through countless awards, nominations, and grant-funded research. Her work spans multiple interrelated clinical foci, including clinical pain, addiction, opioid analgesia, reward responses, the pain experience of addicts, and the phenomenology of addiction in patients with pain. More recently, she has explored pain-opioid interactions on immune cells.
Compton earned her PhD in nursing science from New York University and her MS in neuroscience nursing from Syracuse University. She completed a nursing fellowship at the UCLA Drug Abuse Research Center. She is principal investigator on a $1.6 million R01 grant from the National Institute on Drug Abuse (NIDA) for her project titled, “Opioid-Induced Hyperalgesia in Prescription Opioid Abusers: Effect of Gabapentin.”
Her dedication to nursing education and research also extends to shaping the dialogue of public policy. Serving as an advisory board member for numerous conferences and professional organizations, Compton contributes her expertise to organizations like the American Society of Pain Management Nurses, Substance Abuse and Mental Health Administration, and the Journal of Pain and Symptom Management. She recently discussed new CDC opioid guidelines on The Diane Rehm Show.
Dr. Jim Silliman is the President and Chief Executive Officer of GeneAlign. He has an extensive career in healthcare as a practicing physician, Medical Director, hospital and physician administrator, and business development leader. From 2004 to 2012, Jim served as the Program Medical Director of the Greenville Hospital System University Medical Center and President of the Steadman Hawkins Clinic of the Carolinas.
In the early 2000’s, Jim served as the Executive Director of the Steadman Hawkins Sports Medicine Foundation in Vail, and Senior Associate at the Steadman Hawkins Clinic where he managed every aspect of the business for one of the leading orthopedic surgery organizations in the world. During this time he also founded eMed Ventures, Inc., a venture capital firm that focused on emerging health care technologies that improved hospital and physician interaction and facility management and workflow.
Jim has more than 20 years of experience in knee and shoulder sports medicine and shoulder surgery. A magna cum laude graduate of the University of Louisville Medical School, he completed his residency in Orthopedic Surgery at the University of Texas Southwestern Medical Center and completed fellowships in Lake Tahoe, California, and Vail, Colorado. He is the former program director of the Orthopedic Program at UT Southwestern. He also served for five years as the Team Physician for the U.S. Ski Team.
Jim has served as a Chairman, Director and Advisor on numerous Boards of Directors. He is also a former member of the American Academy of Orthopedic Surgeons and the American Medical Association. Jim has given dozens of presentations in conferences and symposiums across America and has been published in a variety of peer-reviewed medical publications.